Search Within

Population Sciences Research Program

  1. "Clinical Genetics Service"
  2. "Epidemiology and Biostatistics"
  3. "Surgery"
  4. "Semanti Mukherjee"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. Alumni (GSK) (6)
  2. Clinical Genetics Service (6)
  3. Department of Medicine (6)
  4. Epidemiology and Biostatistics (6)
  5. GSK Faculty (6)
  6. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (6)

More Groups

People
  1. Kenneth Offit (6)
  2. Semanti Mukherjee (6)
  3. Marc Ladanyi (5)
  4. Zsofia Stadler (5)
  5. David Jones (4)
  6. Diana Mandelker (4)

More People

Years
  1. 2023 (2)
  2. 2022 (2)
  3. 2021 (1)
  4. 2018 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. Cancer Epidemiology Biomarkers and Prevention (1)
  3. JAMA Oncology (1)
  4. Nature Cancer (1)
  5. Science Translational Medicine (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. American Association for Cancer Research (1)
  3. American Association for the Advancement of Science (1)
  4. American Medical Association (1)
  5. Nature Research (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • POT1 germline pathogenic variants and evolving understanding of tumor spectrum: Evidence for lung cancer predisposition
    Meeting Abstract

    Walsh, M. F.; Mukherjee, S.; Gao, M.; Fiala, E.; Mauguen, A.; Kemel, Y.; Bandlamudi, C.; Mehine, M.; Carlo, M. I.; Murciano-Goroff, Y. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Association of smoking history extracted from electronic health records (EHR) using machine-learning methods and tumor characteristics in patients with lung cancer
    Meeting Abstract

    Mukherjee, S.; Schroeder, A.; Chatterjee, S.; Cadley, J.; Falcon, C. J.; Mehine, M.; Bandlamudi, C.; Chatterjee, A.; Ladanyi, M.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A germline SNP in BRMS1 predisposes patients with lung adenocarcinoma to metastasis and can be ameliorated by targeting c-fos
    Journal Article

    Liu, Y.; Chudgar, N.; Mastrogiacomo, B.; He, D.; Lankadasari, M. B.; Bapat, S.; Jones, G. D.; Sanchez-Vega, F.; Tan, K. S.; Schultz, N.; more...
    Science Translational Medicine (2022)

    Fulltext@MSK | Save
  • Germline pathogenic variants impact clinicopathology of advanced lung cancer
    Journal Article

    Mukherjee, S.; Bandlamudi, C.; Hellmann, M. D.; Kemel, Y.; Drill, E.; Rizvi, H.; Tkachuk, K.; Khurram, A.; Walsh, M. F.; Zauderer, M. G.; more...
    Cancer Epidemiology Biomarkers and Prevention (2022)

    Fulltext@MSK | Save
  • Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
    Journal Article

    Fiala, E. M.; Jayakumaran, G.; Mauguen, A.; Kennedy, J. A.; Bouvier, N.; Kemel, Y.; Fleischut, M. H.; Maio, A.; Salo-Mullen, E. E.; Sheehan, M.; more...
    Nature Cancer (2021)

    Fulltext@MSK | Save
  • Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma
    Journal Article

    Carlo, M. I.; Mukherjee, S.; Mandelker, D.; Vijai, J.; Kemel, Y.; Zhang, L.; Knezevic, A.; Patil, S.; Ceyhan-Birsoy, O.; Huang, K. C.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save